GlassScriptPhysician profile
Sevak Minassian
NPI 1720580103
$539.54
in general payments reported to CMS, 2019-2025
19 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.23 · 2022: $191 · 2023: $112 · 2024: $88.58 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $58.42 | 2022 | |
| Glaxosmithkline, LLC. | $57.86 | 2023 | Arexvy, Shingrix |
| Novo Nordisk INC | $50.90 | 2024 | Wegovy, Saxenda |
| Merck Sharp & Dohme LLC | $41.06 | 2021-2022 | |
| Endogastric Solutions, INC | $37.68 | 2024 | Esophyx |
| Dexcom, INC. | $37.50 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $26.72 | 2025 | |
| Axsome Therapeutics, INC. | $26.24 | 2025 | Symbravo |
| Amgen INC. | $25.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.19 | 2023 | Jardiance |
| Shield Therapeutics INC | $19.37 | 2025 | |
| Hologic Sales and Service, LLC | $18.79 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.66 | 2022 | |
| Janssen Biotech, INC. | $17.97 | 2022 | |
| Scilex Pharmaceuticals INC. | $17.70 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zealand Pharma US, INC. | $17.13 | 2022 | |
| Exact Sciences Corporation | $14.83 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $14.43 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sevak Minassian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.